A detailed history of Millrace Asset Group, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 167,725 shares of LUNG stock, worth $1.06 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
167,725
Holding current value
$1.06 Million
% of portfolio
1.41%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.59 - $8.58 $937,582 - $1.44 Million
167,725 New
167,725 $1.39 Million
Q1 2024

May 13, 2024

BUY
$8.71 - $14.65 $1.67 Million - $2.81 Million
191,580 New
191,580 $1.78 Million
Q2 2022

Jul 28, 2022

SELL
$14.0 - $27.95 $1.1 Million - $2.2 Million
-78,859 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$21.13 - $35.65 $1.67 Million - $2.81 Million
78,859 New
78,859 $1.96 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.